Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Pandora is betting on AI agents to scale service and emotional selling during the peak holiday season
Pandora is using AI agents to scale customer service and replicate emotional in-store selling online, just as peak season puts pressure on margins and teams.
Rembrand’s CEO wants to grow virtual ad placements in streaming, and he’s looking elsewhere for models
Omar Tawakol wants to improve advertising within the streaming world, and is working with advertisers and publishers to improve that experience.
Marketers are keen to use generative AI in ad campaigns, but hidden costs lurk
Marketers across the industry want to use AI to cut down on time spent in creative production. It’s not so simple in practice.